The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.
This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.
The study offers comprehensive outlook of the MRI-guided radiation therapy systems market for the period, 2018 to 2028.
The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.The MRI-guided radiation therapy systems market report includes global as well as emerging players:Elekta ABVIEWRAY TECHNOLOGIES, INC.Device Technologies Australia Pty Ltd.OthersThe study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market.
It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree.
In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.Hospitals Remain the Target Customers for Market PlayersThe study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019.